Search results
Order by most recent / most popular / relevance
Results: 1-10 of 35
Dietary supplement class stayed pending settlement in related litigation
- Shook Hardy & Bacon LLP
- -
- USA
- -
- April 11 2013
Because a virtually identical class action pending before a state court is near settlement, a federal court in California has agreed, in the interest
Sixth Circuit finds Mensing exception in generic drug labeling suit
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 14 2013
The Sixth Circuit Court of Appeals has determined that when a branded drug manufacturer changes its product labeling and the generic manufacturer
Pharmaceutical company to pay $44.6 million to resolve off-label marketing claims
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 14 2013
A federal court in New Jersey has imposed an $18-million criminal penalty on Par Pharmaceutical Cos., which entered a guilty plea to one charge of
False ad suit will proceed against maker of rubber bracelet promoted as athletic enhancer
- Shook Hardy & Bacon LLP
- -
- USA
- -
- February 28 2013
A federal court in California has determined that consumer-fraud claims in a putative nationwide class action filed against a company that owns and
Deceased soldier's family sues supplement maker for wrongful death
- Shook Hardy & Bacon LLP
- -
- USA
- -
- February 28 2013
The parents of a deceased soldier have filed strict liability and wrongful death claims against a dietary supplement manufacturer alleging that their
Federal Court rules against HHS in FOIA litigation over Formaldehyde Carcinogen listing
- Shook Hardy & Bacon LLP
- -
- USA
- -
- February 28 2013
A federal court in the District of Columbia has ruled that the Department of Health and Human Services (HHS) did not "demonstrate beyond material
Parties seek dismissal in case questioning FDA authority to regulate animal-drug compounding
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 25 2012
A Florida pharmacist, whom the Food and Drug Administration (FDA) sought to enjoin from filling veterinarians’ prescriptions for non-food producing animals by compounding from bulk substances without FDA approval, has joined with the U.S. government in seeking the dismissal of its appeal from a district court decision finding that FDA had no authority to do so
No SCOTUS review for ear candlers’ challenge to FDA warning letters
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 25 2012
The U.S. Supreme Court has denied the petition for review filed by the Holistic Candlers and Consumers Association and others claiming that the D.C. Circuit Court of Appeals erred when it determined that Food and Drug Administration (FDA) warning letters are not subject to judicial review
FDA seeks dismissal of whistleblower retaliation claims
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 11 2012
In an ongoing dispute between scientists critical of the Food and Drug Administration’s (FDA’s) medical-device review process, FDA has sought to dismiss claims of adverse employment action allegedly taken in retaliation for whistleblowing
FDA urges SCOTUS to reject review in ear candles case, says warning letters are not reviewable in court
- Shook Hardy & Bacon LLP
- -
- USA
- -
- September 27 2012
The Food and Drug Administration (FDA) has urged the U.S. Supreme Court to reject the petition for review filed by the Holistic Candlers and Consumers Association and companies making ear candle products from a D.C. Circuit Court of Appeals ruling dismissing their challenge to FDA’s warning letters about their products
Current Search
- Jurisdiction - USA
- Workarea - Litigation
- Workarea - Product Liability
- Workarea - Healthcare
- Author - Greg Fowler